Your fact-checks will appear here
Biological database
Bill Gates and his vehicles (Gates Ventures, personal funds, and related initiatives) have backed a series of efforts to speed Alzheimer’s and dementia science: a $1 million agentic‑AI prize and compe...
has not been shown, in the reporting provided, to have publicly recommended or licensed his name to any consumer “smart pill” or cognitive supplement product; instead, marketers have repeatedly used h...
There is no credible evidence in the reporting provided that created, marketed or formally endorsed a product called “”; sources instead document a recurring scam tactic of falsely attaching Gates’ na...
Media reports reliably show that celebrities raise awareness and funds for Alzheimer’s research and care, and many high-profile figures have publicly shared diagnoses or supported charities (e.g., Alz...
Large recent meta-analyses and cohort reviews find statin use is associated with a lower risk of dementia (HRs ~0.79–0.86) and lower Alzheimer’s disease (AD) risk (HR ~0.71–0.82), while some cohort an...
For mild cognitive impairment (MCI) there is no single approved “cure” medication; clinicians focus on diagnosis, monitoring, treating reversible causes and enrolling patients in trials (StatPearls; N...
has directed a mix of personal and philanthropic capital into Alzheimer’s research across venture-style funds, initiatives, data-sharing efforts and targeted grants—most prominently a stake in the , a...
Bill Gates has been an active funder of major Alzheimer’s and dementia initiatives since 2010, but much of that money has come from his personal wealth and Gates Ventures rather than directly from the...
No credible 2024–2025 clinical trial announced a universal “cure” for dementia; instead, the period saw multiple trials showing modest disease‑slowing effects, new drug approvals for early Alzheimer’s...